Amarin Corp PLC (AMRN)
0.5249
+0.03
(+6.17%)
USD |
NASDAQ |
Nov 21, 16:00
0.5286
0.00 (0.00%)
Pre-Market: 08:37
Amarin Enterprise Value: -89.82M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -89.82M |
| November 20, 2024 | -102.37M |
| November 19, 2024 | -103.89M |
| November 18, 2024 | -114.46M |
| November 15, 2024 | -100.06M |
| November 14, 2024 | -91.84M |
| November 13, 2024 | -71.48M |
| November 12, 2024 | -78.55M |
| November 11, 2024 | -75.38M |
| November 08, 2024 | -69.29M |
| November 07, 2024 | -69.01M |
| November 06, 2024 | -62.10M |
| November 05, 2024 | -49.39M |
| November 04, 2024 | -57.00M |
| November 01, 2024 | -64.61M |
| October 31, 2024 | -67.28M |
| October 30, 2024 | -58.02M |
| October 29, 2024 | -53.95M |
| October 28, 2024 | -45.15M |
| October 25, 2024 | -66.29M |
| October 24, 2024 | -69.26M |
| October 23, 2024 | -67.82M |
| October 22, 2024 | -68.02M |
| October 21, 2024 | -69.26M |
| October 18, 2024 | -67.16M |
| Date | Value |
|---|---|
| October 17, 2024 | -71.31M |
| October 16, 2024 | -67.16M |
| October 15, 2024 | -69.01M |
| October 14, 2024 | -66.38M |
| October 11, 2024 | -63.09M |
| October 10, 2024 | -66.05M |
| October 09, 2024 | -67.20M |
| October 08, 2024 | -61.07M |
| October 07, 2024 | -68.76M |
| October 04, 2024 | -56.59M |
| October 03, 2024 | -61.81M |
| October 02, 2024 | -57.33M |
| October 01, 2024 | -50.75M |
| September 30, 2024 | -47.91M |
| September 27, 2024 | -58.23M |
| September 26, 2024 | -66.83M |
| September 25, 2024 | -73.53M |
| September 24, 2024 | -66.87M |
| September 23, 2024 | -72.30M |
| September 20, 2024 | -64.03M |
| September 19, 2024 | -60.54M |
| September 18, 2024 | -61.32M |
| September 17, 2024 | -62.10M |
| September 16, 2024 | -63.74M |
| September 13, 2024 | -59.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-114.46M
Minimum
Nov 18 2024
8.066B
Maximum
Dec 13 2019
1.113B
Average
458.90M
Median
Feb 15 2023
Enterprise Value Benchmarks
| Trinity Biotech PLC | 91.30M |
| Adaptimmune Therapeutics PLC | 26.67M |
| Akari Therapeutics PLC | 24.35M |
| NuCana PLC | -11.87M |
| TC BioPharm (Holdings) PLC | -0.927M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.13M |
| Revenue (Quarterly) | 42.30M |
| Total Expenses (Quarterly) | 67.47M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 38.48% |
| Profit Margin (Quarterly) | -59.42% |
| Earnings Yield | -18.35% |
| Normalized Earnings Yield | -18.26 |